NuVasive, Inc. Focused On Surgeon Support And Showcasing Industry-Leading Products At North American Spine Society 29th Annual Meeting

SAN DIEGO, CA--(Marketwired - November 10, 2014) - NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society (“NASS”) Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company’s attendance underscores NuVasive’s ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company’s products and procedures that have revolutionized the spine industry.

“Absolute Responsiveness™ to our surgeon customers and rapid, differentiated innovation has and will always be a cornerstone of NuVasive’s mission to deliver superior clinical outcomes and transform the quality of patient health care,” said Alex Lukianov, Chairman and Chief Executive Officer of NuVasive. “This year at NASS, we are tremendously excited to provide surgeons with educational opportunities on our product suite, while also showcasing the breadth of our procedurally integrated solutions. Our portfolio of innovative spinal solutions is robust, placing us in an exceptional position to drive the next wave of innovation with a cutting-edge, truly integrated approach.”

Lukianov continued, “Proper alignment of the spine is the most correlative driver to positive long-term outcomes and is of extreme importance to overall health. Our latest innovations address deformity with an integrated assembly of technology that provides an unprecedented global approach to spine surgery. This level of maintaining and improving alignment is the critical next step in revolutionizing spine surgery as we remain dedicated to delivering even better clinical outcomes for our surgeon customers and ever-improving patient results.”

NuVasive’s NASS Exhibit Booth Details

Surgeon support and collaboration will be central to NuVasive’s presence at NASS as the Company exhibits products and procedural innovations that align closely with surgeon needs. Surgeon education will also be a central focus with the Company providing hands-on, in-booth product demonstrations, numerous surgical workshops and other learning opportunities.

In addition, the Company will present its products and procedural innovations that have enabled NuVasive to become the third largest player in the $8.7 billion global spine market. Recently launched products like the Bendini® Spinal Rod Bending System and the XLIF® Decade™ Plate, and new procedures like ALIF and XLIF ACR™ to correct sagittal alignment will be showcased at the NuVasive exhibit booth (#1719). NuVasive will also feature its industry-leading Precept® for posterior fixation, Armada® for deformity, MAS® TLIF, MAS PLIF, XLIF and ALIF products, along with its comprehensive cervical portfolio and NVM5® neuromonitoring system, at its NASS exhibit.

NuVasive’s in-booth presentations at the NASS Annual Meeting include:

Wednesday, November 12, 2014

• 10:00 - 10:30 a.m. PT: XLIF Applications
• 12:00 - 1:00 p.m. PT: Anterior Column Realignment (ACR): Techniques to Restore Global Alignment
• 3:05 - 3:35 p.m. PT: XLIF Single Approach Surgery

Thursday, November 13, 2014

• 9:10 - 9:40 a.m. PT: Surgical Accuracy and Efficiency with Computer-Assisted Rod Bending
• 12:00 - 1:00 p.m. PT: Anterior Column Realignment (ACR): Techniques to Restore Global Alignment
• 3:10 - 3:40 p.m. PT: Single Approach Anterior Cervical Multi-Level Reconstruction

Friday, November 14, 2014

• 10:00 - 10:30 a.m. PT: The Better Way Back®: Getting XLIF Patients Back in the Game
• 12:00 -1:00 p.m. PT: The Better Way Back: How to Support Your Patients

To reference the NASS program, please visit: https://www.spine.org/Documents/Annual%20Meeting/FinalProgram2014.pdf

For more information about NASS please visit: https://www.spine.org/AM/Pages/NASS2014.aspx

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. The Company is the third largest player in the $8.7 billion global spine market. NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company’s principal procedural solution is its Maximum Access Surgery, or MAS, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

NuVasive cautions you that statements included in this press release or made during the 2014 NASS Annual Meeting that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s minimally disruptive surgical products by spine surgeons, development and acceptance of new products or product enhancements, expansion of our network of sales representatives, and the other risks and uncertainties more fully described in NuVasive’s press releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.